To the best of my knowledge, Pakistan has over 700 pharmaceutical companies, but they mainly focus on formulations rather than producing active ingredients, leading to a heavy reliance on imports. This dependency makes locally produced medicines more expensive than those in other regional countries like India. Factors like energy shortages and high utility rates also raise production costs in Pakistan. Additionally, import duties on raw materials and insufficient government backing for local manufacturing hinder competitiveness. The lack of stringent price controls and limited R&D investments further restrict innovation.
Most Pakistani manufacturers operate on a smaller scale, causing inefficiencies and higher unit costs. Currency devaluation also raises the cost of imported inputs, impacting final medicine prices. To address these structural challenges, Pakistan must invest in local production capabilities and develop supportive policies for its pharmaceutical sector.
Sajid Awan
Dubai
UAE
The recent US sanctions on Pakistan’s missile development entities reflect a broader shift in American foreign...
After over a decade since their introduction, the effective implementation of right to information laws in Pakistan...
I think that we have an excess of holidays or days off in Pakistan. Seemingly every month, there are one or two...
In recent days, there have been some reports highlighting how the import of liquefied natural gas is harming the...
With changing societal norms and the rise of social media, many young individuals are struggling to make informed...
As winter takes over, many people in our cities are left to sleep on the streets in the freezing cold. With no...
